<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec11" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Lymphatic uptake</div>
 <p id="Par38" xmlns="http://www.w3.org/1999/xhtml">As demonstrated in Fig. 
  <a rid="Fig2" ref-type="fig" href="#Fig2">2</a>, a fraction of particulate drug, encapsulated by triglycerides is restructured in the endoplasmic reticulum and then released into the mesenteric lymph duct as chylomicrons [
  <a ref-type="bibr" rid="CR66" href="#CR66">66</a>]. Thereafter it reaches the systemic circulation via thoracic lymph [
  <a ref-type="bibr" rid="CR67" href="#CR67">67</a>–
  <a ref-type="bibr" rid="CR69" href="#CR69">69</a>]. Lymphatic uptake becomes ever effective since the drug molecules are bypassed. But, the chain length of triglycerides and solubility of the drug in oil determines the outcome of lymphatic uptake of orally administered lipophilic moieties.
  <div id="Fig2" class="fig">
   <span class="label">Fig. 2</span>
   <div class="caption">
    <p>Lymphatic uptake of ME/NEs</p>
   </div>
   <div xlink:href="12944_2018_757_Fig2_HTML" id="MO2" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </div>
 </p>
</sec>
